Johnson Matthey PLC (LON:JMAT) has been assigned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is GBX 2,750 ($35.93).
Several equities research analysts recently weighed in on JMAT shares. UBS Group reiterated a “sell” rating on shares of Johnson Matthey in a research note on Friday, July 24th. Liberum Capital reiterated a “hold” rating on shares of Johnson Matthey in a research note on Wednesday, July 15th. HSBC increased their price objective on shares of Johnson Matthey from GBX 1,850 ($24.17) to GBX 2,050 ($26.78) and gave the stock a “hold” rating in a research note on Tuesday, June 23rd. Barclays dropped their price objective on shares of Johnson Matthey from GBX 2,650 ($34.62) to GBX 2,450 ($32.01) and set an “equal weight” rating on the stock in a research note on Monday, July 6th. Finally, Berenberg Bank increased their price objective on shares of Johnson Matthey from GBX 2,700 ($35.28) to GBX 3,000 ($39.20) and gave the stock a “buy” rating in a research note on Thursday, September 10th.
In related news, insider Anna Manz acquired 18 shares of the stock in a transaction that occurred on Wednesday, August 19th. The shares were acquired at an average price of GBX 2,384 ($31.15) per share, for a total transaction of £429.12 ($560.65). Also, insider Robert MacLeod sold 11,968 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of GBX 2,245 ($29.33), for a total transaction of £268,681.60 ($351,034.23).
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Article: Most Volatile Stocks – What Investors Need to Know to Maximize ROI
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.